메뉴 건너뛰기




Volumn 14, Issue 3, 2010, Pages 185-190

Pharmacological approach to chronic visceral pain. Focus on oxycodone controlled release: An open multicentric study

Author keywords

Cancer pain; Non cancer pain; Oxycodone; Visceral pain

Indexed keywords

OXYCODONE; NARCOTIC ANALGESIC AGENT;

EID: 77951643453     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (16)

References (19)
  • 1
    • 0000199819 scopus 로고
    • Classification of chronic pain and definition of pain terms
    • MERSKEY H. Classification of chronic pain and definition of pain terms. Pain 1986; 3(suppl): S1-S222.
    • (1986) Pain , vol.3 , Issue.SUPPL.
    • Merskey, H.1
  • 3
    • 42349085789 scopus 로고    scopus 로고
    • Current developments in opioid therapy for management of cancer pain
    • DE LEON-CASASOLA OA. Current developments in opioid therapy for management of cancer pain. Clin J Pain 2008; 24(Suppl. 10): S3-7.
    • (2008) Clin J Pain , vol.24 , Issue.SUPPL. 10
    • De Leon-Casasola, O.A.1
  • 4
    • 44949158798 scopus 로고    scopus 로고
    • Management of cancer pain: ESMO clinical recommendations
    • ESMO GUIDELINES WORKING GROUP
    • ESMO GUIDELINES WORKING GROUP, JOST L. Management of cancer pain: ESMO clinical recommendations. Ann Oncol 2007; 18(Suppl. 2): ii92-94.
    • (2007) Ann Oncol , vol.18 , Issue.SUPPL. 2
    • Jost, L.1
  • 5
    • 31044445939 scopus 로고    scopus 로고
    • No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients
    • RILEY J, ROSS JR, RUTTER D, WELLS AU, GOLLER K, DU BOIS R, WELSH K. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer 2006; 14: 56-64.
    • (2006) Support Care Cancer , vol.14 , pp. 56-64
    • Riley, J.1    Ross, J.R.2    Rutter, D.3    Wells, A.U.4    Goller, K.5    Du Bois, R.6    Welsh, K.7
  • 6
    • 50849129568 scopus 로고    scopus 로고
    • Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain
    • OXYCONTIN TABLETS POSTMARKETING SURVEILLANCE STUDY GROUP CHINA
    • YU SY; OXYCONTIN TABLETS POSTMARKETING SURVEILLANCE STUDY GROUP CHINA. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain. Oncology 2008; 74(Suppl. 1): 46-51.
    • (2008) Oncology , vol.74 , Issue.SUPPL. 1 , pp. 46-51
    • Yu, S.Y.1
  • 7
    • 33745292222 scopus 로고    scopus 로고
    • Pharmacological profile and clinical data in chronic pain management
    • OXYCODONE
    • COLUZZI F, MATTIA C. OXYCODONE. Pharmacological profile and clinical data in chronic pain management. Minerva Anestesiol 2005; 71: 451-560.
    • (2005) Minerva Anestesiol , vol.71 , pp. 451-560
    • Coluzzi, F.1    Mattia, C.2
  • 9
    • 33646151412 scopus 로고    scopus 로고
    • Oxycodone for cancer-related pain: Meta-analysis of randomized controlled trials
    • REID CM, MARTIN RM, STERNE JA, DAVIES AN, HANKS GW. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 837-843.
    • (2006) Arch Intern Med , vol.166 , pp. 837-843
    • Reid, C.M.1    Martin, R.M.2    Sterne, J.A.3    Davies, A.N.4    Hanks, G.W.5
  • 10
    • 44949131642 scopus 로고    scopus 로고
    • Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: Results of an open-label, multicentre, observational study
    • SILVESTRI B, BANDIERI E, DEL PRETE S, et al. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study. Clin Drug Investig 2008; 28: 399-407.
    • (2008) Clin Drug Investig , vol.28 , pp. 399-407
    • Silvestri, B.1    Bandieri, E.2    Del Prete, S.3
  • 11
    • 33947327851 scopus 로고    scopus 로고
    • Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain
    • PAN H, ZHANG Z, ZHANG Y, XU N, LU L, DOU C, GUO Y, WU S, YUE J, WU D, DAI Y. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain. Clin Drug Investig 2007; 27: 259-267.
    • (2007) Clin Drug Investig , vol.27 , pp. 259-267
    • Pan, H.1    Zhang, Z.2    Zhang, Y.3    Xu, N.4    Lu, L.5    Dou, C.6    Guo, Y.7    Wu, S.8    Yue, J.9    Wu, D.10    Dai, Y.11
  • 13
  • 15
    • 65949086139 scopus 로고    scopus 로고
    • Management of acute and chronic pain in the Italian setting and a look toward the future
    • VARRASSI G. Management of acute and chronic pain in the Italian setting and a look toward the future. Clin Drug Invest 2009; 29: 1-3.
    • (2009) Clin Drug Invest , vol.29 , pp. 1-3
    • Varrassi, G.1
  • 17
    • 0041965945 scopus 로고    scopus 로고
    • Attacking pain at its source: New perspectives on opioids
    • DOI 10.1038/nm908
    • STEIN C, SCHÄFER M, MACHELSKA H. Attacking pain at its source: new perspectives on opioids. Nat Med 2003; 9:1003-1008. (Pubitemid 37021779)
    • (2003) Nature Medicine , vol.9 , Issue.8 , pp. 1003-1008
    • Stein, C.1    Schafer, M.2    Machelska, H.3
  • 18
    • 0030781043 scopus 로고    scopus 로고
    • The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated
    • ROSS FB, SMITH MT. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 1997; 73: 151-157.
    • (1997) Pain , vol.73 , pp. 151-157
    • Ross, F.B.1    Smith, M.T.2
  • 19
    • 27744522489 scopus 로고    scopus 로고
    • Antinociceptive effect of oxycodone in diabetic mice
    • NOZAKI C, SAITOH A, TAMURA N, KAMEI J. Antinociceptive effect of oxycodone in diabetic mice. Eur J Pharmacol 2005; 524: 75-79.
    • (2005) Eur J Pharmacol , vol.524 , pp. 75-79
    • Nozaki, C.1    Saitoh, A.2    Tamura, N.3    Kamei, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.